Trial intelligence / Profile preview

Dapoxetine before-and-after study in premature ejaculation

IRCT20200624047912N1Phase 2Completed

Sponsor
Islamic Azad University
Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of dapoxetine in premature ejaculation (PE), sponsored by Islamic Azad University. Primary endpoints: Premature ejaculation time, Satisfaction with treatment and 2 more. Started Apr 2019; status: completed.

02

Drugs

dapoxetine
03

Conditions

premature ejaculation (PE)

Beyond the preview

Go deeper on IRCT20200624047912N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200624047912N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call